Sniecinski Megan — SEC insider filings

SEC reporting owner CIK 1781480. 5 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2020-12-17 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Praxis Precision Medicines, Inc. (PRAX)Chief Operating Officer4——6
BIOCRYST PHARMACEUTICALS INC (BCRX)Chief Business Officer1——1

Insider filings — Sniecinski Megan

FiledFormIssuerReported transactionsSource
2026-11-184Praxis Precision Medicines, Inc. (PRAX)Grant/award (A): 21 @ $278.91EDGAR
2026-05-194Praxis Precision Medicines, Inc. (PRAX)Grant/award (A): 89 @ $167.94EDGAR
2026-01-134Praxis Precision Medicines, Inc. (PRAX)Tax withholding (F): 885 @ $275.74EDGAR
2026-01-124Praxis Precision Medicines, Inc. (PRAX)Grant/award (A): 9,625 @ $0 · Tax withholding (F): 1,087 @ $288.45 · Grant/award (A): 7,700 (derivative) @ $0EDGAR
2020-12-174BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 225,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1781480 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs